CRO Velesco Pharma adds compound management services

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock)
(Image: iStock)

Related tags: Laboratory, Pharmacology, Labrador retriever

The contract research organization (CRO) Velesco Pharma has opened a new laboratory in its Plymouth, MI-based facility to support an increased demand for materials management.

Velesco Pharma's new non-GMP materials handling lab creates and enhances our capabilities to store, dispense, manage inventory and distribute materials such as API, intermediates and compounds transitioning into development​,” Gerry Cox, M.S. CPA, Chief Operating Officer at Velesco told

Cox explained that the company has observed an upturn in the demand for the storage and management of early phase materials in both its non-GMP and GMP operations.

“Our increased capacity has led to an increased focus on meeting this demand​,” he added.

The new capacity complements the company’s current cGMP material storage and dispensing operation in Kalamazoo, MI. However, the new labs adds compound management services for materials with either cGMP or non-GMP requirements. Services include long- and short-term storage of materials at ambient, refrigerated or frozen temperatures, in addition to labeling and distribution.

We have observed demand for these services from smaller pharmaceutical and biotech companies​,” said Cox. “These organizations are actively involved in moving new compounds through the development process but do not have the in-house capabilities to meet their material management needs​.”

Related news

Show more

Related products

show more

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-May-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Q&A: Effective Drug Product Process Development

Q&A: Effective Drug Product Process Development

Catalent Pharma Solutions | 14-Jan-2021 | Insight Guide

In this Q&A, a Catalent Biologics expert shares his expertise with drug product process development challenges, risks and how to mitigate them, the...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Related suppliers

Follow us


View more